Last reviewed · How we verify
Capsaicin, USP 0.0375%
Activates TRPV1 receptors
Activates TRPV1 receptors Used for Pain relief.
At a glance
| Generic name | Capsaicin, USP 0.0375% |
|---|---|
| Also known as | Capsaicin |
| Sponsor | Express Specialty Pharmacy |
| Drug class | Topical analgesic |
| Target | TRPV1 |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 2 |
Mechanism of action
Capsaicin binds to and activates TRPV1 receptors, leading to the sensation of heat and pain relief.
Approved indications
- Pain relief
Common side effects
- Skin irritation
- Burning sensation
- Redness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Capsaicin, USP 0.0375% CI brief — competitive landscape report
- Capsaicin, USP 0.0375% updates RSS · CI watch RSS
- Express Specialty Pharmacy portfolio CI